Research Interests:Clinical trials evaluating novel agents for the treatment of breast; Ovarian and endometrial cancers; PI3K-mTOR inhibitors; HER-2 targeted therapies; Angiogenesis
Clinical Interests:Breast Cancer: Early and advanced stages, hormone receptor positive breast cancers, triple negative breast cancers, HER-2 positive breast cancers, adjuvant (postoperative) treatment, neoadjuvant (preoperative) treatment, metastatic breast cancer treatment, clinical trials. Gynecologic Cancers: Advanced/recurrent ovarian and endometrial cancers, clinical trials.
Research Interests:questions of drug resistance and the hereditary factors involved in cancer occurrence and treatment; applying molecular genetics to a more complete understanding of both hereditary influences and the potential for targeted treatments.
Clinical Interests:myelodysplasia; leukemia; and cancers of the lung, colon, and lymph nodes.
Clinical Interests:Breast Cancer
Research Interests:Clinical trials in head and neck cancer; Sarcoma; Genitourinary (GU) cancer; Thyroid cancer; Endocrine cancers
Clinical Interests:Head and neck cancer; Genitourinary (GU) cancers; sarcomas; thyroid cancer.
Research Interests:Drug Resistance; Hodgkin's Disease; Lymphomas; Molecular Technology.
Clinical Interests:Consultations on Patients with Lymphomas; Hodgkin's disease; Breast Cancer; Melanoma; Cancer Chemotherapy; Epidemiology; Public Health
Research Interests:Breast cancer; HER-2/neu/ErbB-2; IGF1 receptor; EGF receptor; Growth factor receptor tyrosine protein kinases in malignancy; Estrogen receptor, Signal transduction, breast cancer clinical trials
Clinical Interests:Breast Cancer
Research Interests:Phase I clinical trials; Cancer pharmacology; Angiogenesis
Clinical Interests:Some particular areas of past and present involvement in the development of novel therapeutics include high dose chemotherapy, the modulation/ reversal of drug resistance, growth factors, vaccines, signal transduction pathway inhibitors, cell cycle inhibitors, and the therapeutic use of antiangiogenisis agents. In this area, I have interest in developing pharmacodynamic markers of antiangiogenic effects in the clinic including MRI and PET imaging, circulating endothelial cells, monitoring interstitial fluid pressures and the evaluation of tumor biopsies after therapy. The clinical role of pathways to resistance is an area of interest and I have led clinical trials of HGF/MET inhibitors combined with VEGF-targeted therapies.
Clinical Interests:Melanomal; Prostate Cancer
Research Interests:Clinical trial design; Novel therapeutics; Radiosensitizers; Prognostic biomarkers
Clinical Interests:Lung cancer; mesothelioma; thymoma; head and neck cancer; thyroid cancer; mediastinal and chest wall tumors
Research Interests:Clinical trials; Translational research; Novel therapeutics; Personalized medicine
Clinical Interests:Lung Cancer; Thoracic Oncology; Personalized Medicine
Research Interests:Molecular cancer epidemiology; Cancer prognosis; Melanoma - skin cancer; Lung cancer; Pancreatic Neuroendocrine Tumors (PNETs); Tuberous Sclerosis Complex; Next-generation sequencing; Somatic tumor mutations; Germline genetic variation; Immunohistochemistry-based biomarkers; Biospecimens and biobanking; Lifestyle choices associated with cancer outcome.
Research Interests:Early phase clinical trials; Biomarker studies; Personalized medicine for cancer treatment.
Clinical Interests:Lung cancer; Thoracic Oncology; Personalized Cancer Medicine; Clinical Trials for Lung cancer; Tumor profiling; Tumor biomakers
Research Interests:Clinical research; Pharmacology; Anti cancer drug development; Early clinical trials in cancer
Clinical Interests:gastrointestinal cancer; colon cancer; pancreatic cancer; gastric cancer; biliary cancer
Clinical Interests:high risk cancer genetics; breast cancer.
Research Interests:Cell migration; Kinase signaling; Phosphorylation; Cytoskeleton; Engulfment; Apoptosis; C. elegans; Cancer biology
Clinical Interests:genitourinary cancers
Clinical Interests:lymphoma; leukemia.
Research Interests:Prognostic and predictive markers in melanoma and renal cell carcinoma; Development of new drugs for melanoma and renal cell carcinoma
Clinical Interests:Melanoma; renal cell carcinoma; breast cancer Clinical trials using immune and biologic therapies
Research Interests:Cancer prevention and therapy; Lung carcinogenesis; Epithelial cell biology; Personalized medicine; Molecular targets; Drug development; Transcription Factor CREB; Inflammation; Cytokines and chemokines and receptors; Biomarkers for early detection and therapy
Research Interests:Clinical research in gastrointestinal malignancies; Gastroesphageal, pancreatic, and colorectal cancers; Brain tumors; Epstein-Barr virus-associated malignancies
Clinical Interests:Colorectal cancer; pancreatic cancer; esophageal cancer; gastric cancer; gall bladder cancer; anal cancer; biliary cancer; liver cancer; neuroendocrine tumors; brain tumors; non-Hodgkin's lymphoma (NHL); Hodgkin's disease; Kaposi's sarcoma
Clinical Interests:breast cancer; hematologic malignancies; lymphoma; solid tumors
Research Interests:Dr. Lilenbaum’s life has been about caring for patients with lung cancer. He has done pioneering work in defining the best way to treat lung cancer—particularly in older patients. He is a proven leader who is committed to enhancing Smilow Cancer Hospital’s ability to provide the very best care to our patients.
Clinical Interests:lung cancer; lung cancer treatment in older patients
Research Interests:Lung cancer; EGFR; Targeted therapy; Personalized medicine
Clinical Interests:Targeted Cancer Therapy; Thoracic Oncology; EGFR positive lung cancer treatment; Clinical Trials for lung cancer
Research Interests:Clinical trials for prostate and bladder cancers
Clinical Interests:genitourinary cancer; prostate cancer; clinical trials for men with prostate and bladder cancer.
Research Interests:Breast cancer; Translational cancer research; Developing pharmacogenomic markers of response to breast cancer therapy and identifying methods to select the optimal treatment for each patient
Clinical Interests:breast cancer; cancer genetics.
Research Interests:Sickle cell disease; Prostate cancer; Bladder cancer; Testicular cancer; Clinical trials; Clinical trials design.
Clinical Interests:sickle cell disease; urological cancers (prostate, bladder, testicle)
Clinical Interests:lung; breast cancer.
Research Interests:Delivery of treatment summaries and survivorship care plans; Symptom management; Interventions that optimize health and longevity in the cancer survivor
Clinical Interests:palliative care; cancer survivorship; breast cancer.
Clinical Interests:developing new clinical trials to provide new treatment options for patients with gastrointestinal cancers.
Research Interests:Cancer drug development; Cancer immunotherapy and novel agents
Clinical Interests:melanoma; immunologic therapy; renal cell (kidney) carcinoma; Phase I trials